Daniel B. Soland is COO & VP at VIROPHARMA INC (VPHM). They have made 11 open-market trades across 5 companies since 2007, most recently 2025-05-29.
CIK 0001318485
10 open-market purchases totalling $1.3M since 2007, against 1 sale. Across 5 scored buys the stock is down 23.1% at ninety days, and 26.1 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 20% | 20% |
| Avg Move | -0.0% | -18.8% | -23.1% |
| Alpha | -1.0% | -20.2% | -26.1% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DBVT | BUY | 2023-08-01 | 2023-08-03 | $1.62 | $24K | +1.3% | +15.1% | -32.9% |
| IDRA | BUY | 2021-06-18 | 2021-06-21 | $1.19 | $60K | -5.6% | -15.2% | -17.6% |
| IDRA | BUY | 2021-03-05 | 2021-03-05 | $3.90 | $39K | +10.8% | -70.8% | -74.5% |
| KALV | BUY | 2019-09-26 | 2019-09-30 | $11.87 | $213K | -9.9% | -9.3% | +34.8% |
| ACAD | BUY | 2018-03-01 | 2018-03-02 | $23.49 | $235K | +3.3% | -13.9% | -25.4% |
| VPHM | SELL | 2012-03-01 | 2012-03-06 | $32.99 | $990K | N/A | N/A | N/A |
| VPHM | BUY | 2010-05-06 | 2010-05-07 | $12.22 | $244K | N/A | N/A | N/A |
| VPHM | BUY | 2009-03-12 | 2009-03-13 | $4.05 | $122K | N/A | N/A | N/A |
| VPHM | BUY | 2007-11-07 | 2007-11-09 | $7.26 | $73K | N/A | N/A | N/A |
| VPHM | BUY | 2007-11-01 | 2007-11-05 | $8.31 | $125K | N/A | N/A | N/A |
| VPHM | BUY | 2007-08-16 | 2007-08-17 | $8.00 | $120K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.